Newsbenzinga
Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal
· Published
Article summary
Merck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostics, and bioprocessing footprint.
An excerpt from the original article.
Comments —
Loading comments…